BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10758022)

  • 21. Antiretroviral drug resistance among HIV-1 infected children failing treatment.
    Mullen J; Leech S; O'Shea S; Chrystie IL; Du Mont G; Ball C; Sharland M; Cottam F; Zuckerman M; Rice P; Easterbrook P
    J Med Virol; 2002 Nov; 68(3):299-304. PubMed ID: 12226814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of short-term success of antiretroviral therapy in HIV infection.
    Oette M; Kroidl A; Göbels K; Stabbert A; Menge M; Sagir A; Kuschak D; O'hanley T; Bode JG; Häussinger D
    J Antimicrob Chemother; 2006 Jul; 58(1):147-53. PubMed ID: 16687458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Strategies for optimizing adherence to highly active antiretroviral therapy: lessons from research and clinical practice.
    Stone VE
    Clin Infect Dis; 2001 Sep; 33(6):865-72. PubMed ID: 11512092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A time-to-prescription-refill measure of antiretroviral adherence predicted changes in viral load in HIV.
    Grossberg R; Zhang Y; Gross R
    J Clin Epidemiol; 2004 Oct; 57(10):1107-10. PubMed ID: 15528063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance.
    Sethi AK; Celentano DD; Gange SJ; Moore RD; Gallant JE
    Clin Infect Dis; 2003 Oct; 37(8):1112-8. PubMed ID: 14523777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emergence of HIV-1 drug resistance during antiretroviral treatment.
    Rong L; Feng Z; Perelson AS
    Bull Math Biol; 2007 Aug; 69(6):2027-60. PubMed ID: 17450401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV-1 drug resistance assays in clinical management.
    Martinez-Picado J; D'Aquila R
    AIDS Clin Care; 1998 Nov; 10(11):81-5, 87-8. PubMed ID: 11365861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between pharmacy medication refill-based adherence rates and cd4 count and viral-load responses: A retrospective analysis in treatment-experienced adults with HIV.
    Townsend ML; Jackson GL; Smith R; Wilson KH
    Clin Ther; 2007 Apr; 29(4):711-6. PubMed ID: 17617294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.
    Coffie PA; Ekouevi DK; Chaix ML; Tonwe-Gold B; Clarisse AB; Becquet R; Viho I; N'dri-Yoman T; Leroy V; Abrams EJ; Rouzioux C; Dabis F
    Clin Infect Dis; 2008 Feb; 46(4):611-21. PubMed ID: 18197758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advances in the virology of HIV infections and implications for clinical management.
    Vella S
    AIDS Clin Care; 1998 Mar; 10(3):17-9. PubMed ID: 11365117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive clinical adherence interventions to enable antiretroviral therapy: a case report.
    Nicca D; Moody K; Elzi L; Spirig R
    J Assoc Nurses AIDS Care; 2007; 18(6):44-53. PubMed ID: 17991598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiretroviral therapy in HIV/AIDS: update from San Francisco.
    Laurence J
    AIDS Read; 2000 Mar; 10(3):133-4. PubMed ID: 10758008
    [No Abstract]   [Full Text] [Related]  

  • 33. [Psychological variables and adherence to antiretroviral treatment].
    Gordillo Alvarez-Valdés MV; González-Lahoz J
    An Med Interna; 2000 Jan; 17(1):38-41. PubMed ID: 10730405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monitoring adherence and defaulting for antiretroviral therapy in 5 East african countries: an urgent need for standards.
    Chalker J; Andualem T; Minzi O; Ntaganira J; Ojoo A; Waako P; Ross-Degnan D
    J Int Assoc Physicians AIDS Care (Chic); 2008; 7(4):193-9. PubMed ID: 18626124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Impact of new antiretroviral therapy in HIV infected patients with virologic failure].
    Costagliola D
    Med Sci (Paris); 2012; 28(8-9):706-7. PubMed ID: 22920871
    [No Abstract]   [Full Text] [Related]  

  • 36. [Adherence to very active antiretroviral treatment: impact of individualized assessment].
    Knobel H; Carmona A; López JL; Gimeno JL; Saballs P; González A; Guelar A; Díez A
    Enferm Infecc Microbiol Clin; 1999 Feb; 17(2):78-81. PubMed ID: 10193067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measuring adherence to treatment of paediatric HIV/AIDS.
    Naar-King S; Frey M; Harris M; Arfken C
    AIDS Care; 2005 Apr; 17(3):345-9. PubMed ID: 15832882
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiretroviral therapies from the patient's perspective.
    Meystre-Agustoni G; Dubois-Arber F; Cochand P; Telenti A
    AIDS Care; 2000 Dec; 12(6):717-21. PubMed ID: 11177450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Standard of care: promoting antiretroviral adherence in clinical care.
    Harman JJ; Amico KR; Johnson BT
    AIDS Care; 2005 Feb; 17(2):237-51. PubMed ID: 15763717
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment. Antiretroviral adherence results in lower health care costs, study says.
    AIDS Policy Law; 2010 Feb; 25(3):1. PubMed ID: 20419883
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.